SCHEMBL9199766

SCHEMBL9199766

CC(=Cc1c(-c2ccccc2)nn2ccccc12)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.46
RXRA P19793 2/20 0.45
RXRB P28702 2/20 0.45
RXRG P48443 2/20 0.45
NR4A2 P43354 1/20 0.45
ADORA2A P29274 3/20 0.44
ADORA1 P30542 3/20 0.44
ADORA2B P29275 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
AKR1C3 P42330 1/20 0.41
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 1/20 0.41
KCNH2 Q12809 2/20 0.39
HDAC1 Q13547 2/20 0.39
AKT1 P31749 1/20 0.38
MAPK1 P28482 1/20 0.38
IGF1R P08069 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199761 1.00 EGFR (0.46) EGFRRXRARXRBRXRGNR4A2
SCHEMBL9197385 0.86 ADORA2A (0.44) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL9197388 0.86 ADORA2A (0.44) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL9201645 0.81 ADORA2A (0.54) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL9201649 0.81 ADORA2A (0.54) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL8811759 0.78 ADORA2A (0.45) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL9194515 0.78 ADORA2A (0.52) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL9194513 0.78 ADORA2A (0.52) EGFRADORA2AADORA1ADORA2BADORA3
SCHEMBL7294663 0.78 ADORA2A (0.56) EGFRRXRARXRBNR4A2ADORA2A
SCHEMBL7294668 0.78 ADORA2A (0.56) EGFRRXRARXRBNR4A2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299209-B1 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-09-13 EP disclosed
US-5296490-A Pharmaceutically useful pyrazolopyridines FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
US-5179103-A Diuretics, hypotensive agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-01-12 US disclosed
US-5102878-A Treating psychological, bone, cardiovascular, blood disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5102869-A Urogenital disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5087629-A Diuretics, hypotensive agents; cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-11 US disclosed
US-4994453-A Treating asthma, diabetes, obesity, immunosuppression FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-19 US disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed